Stay updated on Biogen Press Releases
Sign up to get notified when there's something new on the Biogen Press Releases page.
Latest updates to the Biogen Press Releases page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page has removed the section on Diversity, Equity, & Inclusion, which may indicate a shift in focus or priorities.SummaryDifference1%
- Check22 days agoNo Change Detected
- Check58 days agoChange DetectedThe web page has added a new section or content labeled 'Page 3'.SummaryDifference0.7%
- Check65 days agoChange DetectedThe page now includes a significant update regarding Biogen's investigational therapy BIIB080, which has received FDA Fast Track Designation for Alzheimer's Disease, while a previous collaboration announcement with Stoke Therapeutics has been removed.SummaryDifference17%
- Check73 days agoChange DetectedThe page has been updated to include a significant regulatory review update regarding Lecanemab for early Alzheimer's disease, while a previous report on Biogen's financial results has been removed.SummaryDifference10%
- Check80 days agoChange DetectedThe webpage now includes an announcement about Biogen's plans for a new global headquarters and innovation hub in Kendall Square, while the previous FDA approval for LEQEMBI® has been removed.SummaryDifference11%
- Check102 days agoChange DetectedThe webpage now includes a significant update regarding Biogen's financial reporting schedule, specifically stating that the company will report its fourth quarter and full year 2024 financial results on February 12, 2025.SummaryDifference11%
Stay in the know with updates to Biogen Press Releases
Enter your email address, and we'll notify you when there's something new on the Biogen Press Releases page.